Global Repeat Expansion Disorders Treatment Market Research Report 2023

The global Repeat Expansion Disorders Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Repeat Expansion Disorders Treatment in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Repeat Expansion Disorders Treatment include Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, Inc., Healx, Intellia Therapeutics, Inc., Editas Medicine, Bluebird bio, Inc. and Sanofi, Merck & Co., Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Repeat Expansion Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Repeat Expansion Disorders Treatment.

The Repeat Expansion Disorders Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Repeat Expansion Disorders Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Repeat Expansion Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Oral

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Repeat Expansion Disorders Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Repeat Expansion Disorders Treatment Market Perspective (2018-2029)

2.2 Repeat Expansion Disorders Treatment Growth Trends by Region

2.2.1 Global Repeat Expansion Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Repeat Expansion Disorders Treatment Historic Market Size by Region (2018-2023)

2.2.3 Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2024-2029)

2.3 Repeat Expansion Disorders Treatment Market Dynamics

2.3.1 Repeat Expansion Disorders Treatment Industry Trends

2.3.2 Repeat Expansion Disorders Treatment Market Drivers

2.3.3 Repeat Expansion Disorders Treatment Market Challenges

2.3.4 Repeat Expansion Disorders Treatment Market Restraints

3.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue

3.1.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue (2018-2023)

3.1.2 Global Repeat Expansion Disorders Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Repeat Expansion Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Repeat Expansion Disorders Treatment Revenue

3.4 Global Repeat Expansion Disorders Treatment Market Concentration Ratio

3.4.1 Global Repeat Expansion Disorders Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Repeat Expansion Disorders Treatment Revenue in 2022

3.5 Repeat Expansion Disorders Treatment Key Players Head office and Area Served

3.6 Key Players Repeat Expansion Disorders Treatment Product Solution and Service

3.7 Date of Enter into Repeat Expansion Disorders Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Type (2018-2023)

4.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Application (2018-2023)

5.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Repeat Expansion Disorders Treatment Market Size (2018-2029)

6.2 North America Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)

6.4 North America Repeat Expansion Disorders Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Repeat Expansion Disorders Treatment Market Size (2018-2029)

7.2 Europe Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)

7.4 Europe Repeat Expansion Disorders Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size (2018-2029)

8.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Repeat Expansion Disorders Treatment Market Size (2018-2029)

9.2 Latin America Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)

9.4 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size (2018-2029)

10.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer, Inc.

11.1.1 Pfizer, Inc. Company Detail

11.1.2 Pfizer, Inc. Business Overview

11.1.3 Pfizer, Inc. Repeat Expansion Disorders Treatment Introduction

11.1.4 Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.1.5 Pfizer, Inc. Recent Development

11.2 CRISPR Therapeutics

11.2.1 CRISPR Therapeutics Company Detail

11.2.2 CRISPR Therapeutics Business Overview

11.2.3 CRISPR Therapeutics Repeat Expansion Disorders Treatment Introduction

11.2.4 CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.2.5 CRISPR Therapeutics Recent Development

11.3 Acorda Therapeutics

11.3.1 Acorda Therapeutics Company Detail

11.3.2 Acorda Therapeutics Business Overview

11.3.3 Acorda Therapeutics Repeat Expansion Disorders Treatment Introduction

11.3.4 Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.3.5 Acorda Therapeutics Recent Development

11.4 Capsida Biotherapeutics Inc.

11.4.1 Capsida Biotherapeutics Inc. Company Detail

11.4.2 Capsida Biotherapeutics Inc. Business Overview

11.4.3 Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Introduction

11.4.4 Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.4.5 Capsida Biotherapeutics Inc. Recent Development

11.5 Larimar Therapeutics, Inc.

11.5.1 Larimar Therapeutics, Inc. Company Detail

11.5.2 Larimar Therapeutics, Inc. Business Overview

11.5.3 Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction

11.5.4 Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.5.5 Larimar Therapeutics, Inc. Recent Development

11.6 Healx, Intellia Therapeutics, Inc.

11.6.1 Healx, Intellia Therapeutics, Inc. Company Detail

11.6.2 Healx, Intellia Therapeutics, Inc. Business Overview

11.6.3 Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction

11.6.4 Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.6.5 Healx, Intellia Therapeutics, Inc. Recent Development

11.7 Editas Medicine

11.7.1 Editas Medicine Company Detail

11.7.2 Editas Medicine Business Overview

11.7.3 Editas Medicine Repeat Expansion Disorders Treatment Introduction

11.7.4 Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.7.5 Editas Medicine Recent Development

11.8 Bluebird bio, Inc.

11.8.1 Bluebird bio, Inc. Company Detail

11.8.2 Bluebird bio, Inc. Business Overview

11.8.3 Bluebird bio, Inc. Repeat Expansion Disorders Treatment Introduction

11.8.4 Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.8.5 Bluebird bio, Inc. Recent Development

11.9 Sanofi, Merck & Co., Inc.

11.9.1 Sanofi, Merck & Co., Inc. Company Detail

11.9.2 Sanofi, Merck & Co., Inc. Business Overview

11.9.3 Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Introduction

11.9.4 Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.9.5 Sanofi, Merck & Co., Inc. Recent Development

11.10 H. Lundbeck A/S

11.10.1 H. Lundbeck A/S Company Detail

11.10.2 H. Lundbeck A/S Business Overview

11.10.3 H. Lundbeck A/S Repeat Expansion Disorders Treatment Introduction

11.10.4 H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.10.5 H. Lundbeck A/S Recent Development

11.11 Cellectis SA

11.11.1 Cellectis SA Company Detail

11.11.2 Cellectis SA Business Overview

11.11.3 Cellectis SA Repeat Expansion Disorders Treatment Introduction

11.11.4 Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.11.5 Cellectis SA Recent Development

11.12 Bio-Techne

11.12.1 Bio-Techne Company Detail

11.12.2 Bio-Techne Business Overview

11.12.3 Bio-Techne Repeat Expansion Disorders Treatment Introduction

11.12.4 Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.12.5 Bio-Techne Recent Development

11.13 GlaxoSmithKline plc

11.13.1 GlaxoSmithKline plc Company Detail

11.13.2 GlaxoSmithKline plc Business Overview

11.13.3 GlaxoSmithKline plc Repeat Expansion Disorders Treatment Introduction

11.13.4 GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.13.5 GlaxoSmithKline plc Recent Development

11.14 Allergan Aurobindo Pharma Ltd.

11.14.1 Allergan Aurobindo Pharma Ltd. Company Detail

11.14.2 Allergan Aurobindo Pharma Ltd. Business Overview

11.14.3 Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Introduction

11.14.4 Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.14.5 Allergan Aurobindo Pharma Ltd. Recent Development

11.15 Sun Pharmaceutical Industries Ltd.

11.15.1 Sun Pharmaceutical Industries Ltd. Company Detail

11.15.2 Sun Pharmaceutical Industries Ltd. Business Overview

11.15.3 Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Introduction

11.15.4 Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.15.5 Sun Pharmaceutical Industries Ltd. Recent Development

11.16 Torrent Pharmaceuticals Ltd.

11.16.1 Torrent Pharmaceuticals Ltd. Company Detail

11.16.2 Torrent Pharmaceuticals Ltd. Business Overview

11.16.3 Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction

11.16.4 Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.16.5 Torrent Pharmaceuticals Ltd. Recent Development

11.17 Intas Pharmaceuticals Ltd.

11.17.1 Intas Pharmaceuticals Ltd. Company Detail

11.17.2 Intas Pharmaceuticals Ltd. Business Overview

11.17.3 Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction

11.17.4 Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.17.5 Intas Pharmaceuticals Ltd. Recent Development

11.18 Cipla Ltd

11.18.1 Cipla Ltd Company Detail

11.18.2 Cipla Ltd Business Overview

11.18.3 Cipla Ltd Repeat Expansion Disorders Treatment Introduction

11.18.4 Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)

11.18.5 Cipla Ltd Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Oral

    Table 3. Key Players of Injection

    Table 4. Global Repeat Expansion Disorders Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Repeat Expansion Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Repeat Expansion Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Repeat Expansion Disorders Treatment Market Share by Region (2018-2023)

    Table 8. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Repeat Expansion Disorders Treatment Market Share by Region (2024-2029)

    Table 10. Repeat Expansion Disorders Treatment Market Trends

    Table 11. Repeat Expansion Disorders Treatment Market Drivers

    Table 12. Repeat Expansion Disorders Treatment Market Challenges

    Table 13. Repeat Expansion Disorders Treatment Market Restraints

    Table 14. Global Repeat Expansion Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Repeat Expansion Disorders Treatment Market Share by Players (2018-2023)

    Table 16. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2022)

    Table 17. Ranking of Global Top Repeat Expansion Disorders Treatment Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Repeat Expansion Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Repeat Expansion Disorders Treatment Product Solution and Service

    Table 21. Date of Enter into Repeat Expansion Disorders Treatment Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Repeat Expansion Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2018-2023)

    Table 25. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2024-2029)

    Table 27. Global Repeat Expansion Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Repeat Expansion Disorders Treatment Revenue Market Share by Application (2018-2023)

    Table 29. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Repeat Expansion Disorders Treatment Revenue Market Share by Application (2024-2029)

    Table 31. North America Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Repeat Expansion Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Repeat Expansion Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Repeat Expansion Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Pfizer, Inc. Company Detail

    Table 47. Pfizer, Inc. Business Overview

    Table 48. Pfizer, Inc. Repeat Expansion Disorders Treatment Product

    Table 49. Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 50. Pfizer, Inc. Recent Development

    Table 51. CRISPR Therapeutics Company Detail

    Table 52. CRISPR Therapeutics Business Overview

    Table 53. CRISPR Therapeutics Repeat Expansion Disorders Treatment Product

    Table 54. CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 55. CRISPR Therapeutics Recent Development

    Table 56. Acorda Therapeutics Company Detail

    Table 57. Acorda Therapeutics Business Overview

    Table 58. Acorda Therapeutics Repeat Expansion Disorders Treatment Product

    Table 59. Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 60. Acorda Therapeutics Recent Development

    Table 61. Capsida Biotherapeutics Inc. Company Detail

    Table 62. Capsida Biotherapeutics Inc. Business Overview

    Table 63. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Product

    Table 64. Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 65. Capsida Biotherapeutics Inc. Recent Development

    Table 66. Larimar Therapeutics, Inc. Company Detail

    Table 67. Larimar Therapeutics, Inc. Business Overview

    Table 68. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Product

    Table 69. Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 70. Larimar Therapeutics, Inc. Recent Development

    Table 71. Healx, Intellia Therapeutics, Inc. Company Detail

    Table 72. Healx, Intellia Therapeutics, Inc. Business Overview

    Table 73. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Product

    Table 74. Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 75. Healx, Intellia Therapeutics, Inc. Recent Development

    Table 76. Editas Medicine Company Detail

    Table 77. Editas Medicine Business Overview

    Table 78. Editas Medicine Repeat Expansion Disorders Treatment Product

    Table 79. Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 80. Editas Medicine Recent Development

    Table 81. Bluebird bio, Inc. Company Detail

    Table 82. Bluebird bio, Inc. Business Overview

    Table 83. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Product

    Table 84. Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 85. Bluebird bio, Inc. Recent Development

    Table 86. Sanofi, Merck & Co., Inc. Company Detail

    Table 87. Sanofi, Merck & Co., Inc. Business Overview

    Table 88. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Product

    Table 89. Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 90. Sanofi, Merck & Co., Inc. Recent Development

    Table 91. H. Lundbeck A/S Company Detail

    Table 92. H. Lundbeck A/S Business Overview

    Table 93. H. Lundbeck A/S Repeat Expansion Disorders Treatment Product

    Table 94. H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 95. H. Lundbeck A/S Recent Development

    Table 96. Cellectis SA Company Detail

    Table 97. Cellectis SA Business Overview

    Table 98. Cellectis SA Repeat Expansion Disorders Treatment Product

    Table 99. Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 100. Cellectis SA Recent Development

    Table 101. Bio-Techne Company Detail

    Table 102. Bio-Techne Business Overview

    Table 103. Bio-Techne Repeat Expansion Disorders Treatment Product

    Table 104. Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 105. Bio-Techne Recent Development

    Table 106. GlaxoSmithKline plc Company Detail

    Table 107. GlaxoSmithKline plc Business Overview

    Table 108. GlaxoSmithKline plc Repeat Expansion Disorders Treatment Product

    Table 109. GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 110. GlaxoSmithKline plc Recent Development

    Table 111. Allergan Aurobindo Pharma Ltd. Company Detail

    Table 112. Allergan Aurobindo Pharma Ltd. Business Overview

    Table 113. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Product

    Table 114. Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 115. Allergan Aurobindo Pharma Ltd. Recent Development

    Table 116. Sun Pharmaceutical Industries Ltd. Company Detail

    Table 117. Sun Pharmaceutical Industries Ltd. Business Overview

    Table 118. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Product

    Table 119. Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 120. Sun Pharmaceutical Industries Ltd. Recent Development

    Table 121. Torrent Pharmaceuticals Ltd. Company Detail

    Table 122. Torrent Pharmaceuticals Ltd. Business Overview

    Table 123. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product

    Table 124. Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 125. Torrent Pharmaceuticals Ltd. Recent Development

    Table 126. Intas Pharmaceuticals Ltd. Company Detail

    Table 127. Intas Pharmaceuticals Ltd. Business Overview

    Table 128. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product

    Table 129. Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 130. Intas Pharmaceuticals Ltd. Recent Development

    Table 131. Cipla Ltd Company Detail

    Table 132. Cipla Ltd Business Overview

    Table 133. Cipla Ltd Repeat Expansion Disorders Treatment Product

    Table 134. Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)

    Table 135. Cipla Ltd Recent Development

    Table 136. Research Programs/Design for This Report

    Table 137. Key Data Information from Secondary Sources

    Table 138. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Repeat Expansion Disorders Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Repeat Expansion Disorders Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Oral Features

    Figure 4. Injection Features

    Figure 5. Global Repeat Expansion Disorders Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Repeat Expansion Disorders Treatment Market Share by Application: 2022 VS 2029

    Figure 7. Hospital Pharmacies Case Studies

    Figure 8. Retail Pharmacies Case Studies

    Figure 9. Online Pharmacies Case Studies

    Figure 10. Repeat Expansion Disorders Treatment Report Years Considered

    Figure 11. Global Repeat Expansion Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Repeat Expansion Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Repeat Expansion Disorders Treatment Market Share by Region: 2022 VS 2029

    Figure 14. Global Repeat Expansion Disorders Treatment Market Share by Players in 2022

    Figure 15. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Repeat Expansion Disorders Treatment Revenue in 2022

    Figure 17. North America Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Repeat Expansion Disorders Treatment Market Share by Country (2018-2029)

    Figure 19. United States Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Repeat Expansion Disorders Treatment Market Share by Country (2018-2029)

    Figure 23. Germany Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Repeat Expansion Disorders Treatment Market Share by Region (2018-2029)

    Figure 31. China Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Repeat Expansion Disorders Treatment Market Share by Country (2018-2029)

    Figure 39. Mexico Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Repeat Expansion Disorders Treatment Market Share by Country (2018-2029)

    Figure 43. Turkey Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Pfizer, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 46. CRISPR Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 47. Acorda Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 48. Capsida Biotherapeutics Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 49. Larimar Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 50. Healx, Intellia Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 51. Editas Medicine Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 52. Bluebird bio, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 53. Sanofi, Merck & Co., Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 54. H. Lundbeck A/S Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 55. Cellectis SA Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 56. Bio-Techne Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 58. Allergan Aurobindo Pharma Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 59. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 60. Torrent Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 61. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 62. Cipla Ltd Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed